Ankita Srivastava | Head-PV
Vistagen

Ankita Srivastava is a seasoned pharmacovigilance professional with a proven track record in drug development and pharmacovigilance. As the Head of Pharmacovigilance at Vistagen, Ankita brings a wealth of experience and expertise to the table. With a strong background in medicine and drug safety regulations, she is dedicated to ensuring the safety and well-being of patients through the effective management of adverse events and drug-related risks.

Ankita is known for her strategic leadership and innovative approach to pharmacovigilance. She has a keen eye for leveraging technology and data analytics to enhance pharmacovigilance processes and drive performance improvements. Her commitment to excellence and continuous improvement has earned her a reputation as a trusted leader in the field.

At the World Drug Safety Congress Americas 2025, Ankita will be sharing her insights on safety data monitoring, and assesements in drug safety. Her presentation will focus on the latest trends and best practices for safety professionals and industry partners, highlighting the importance of collaboration and cutting-edge solutions in ensuring drug safety and regulatory compliance.

With Ankita's expertise and passion for pharmacovigilance, attendees can expect to gain valuable knowledge and practical strategies for optimizing drug safety processes and enhancing patient outcomes. Don't miss the opportunity to learn from Ankita Srivastava and join the conversation on driving innovation and performance in drug safety at the upcoming conference.